NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM
NASDAQ TRADE HALT INBX.O VOLATILITY TRADING PAUSE AT 09:33 AM
Recent news on Inhibrx
See all newsInhibrx Q1 net loss narrows as R&D costs fall
Brief: Inhibrx Reports Interim Phase 2 Data for INBRX-106 in First-Line HNSCC; Initial Results Demonstrate Potential Costimulatory Benefit Over PD-1 Monotherapy
Brief: Inhibrx to host webcast presentation to provide clinical update on INBRX-106 HexAgon study in first line HNSCC
Merck, rivals eye Inhibrx experimental cancer drug tied to Keytruda, sources say
U.S. STOCKS ON THE MOVE-Tesla, AT&T, Yesway